• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动在卒中中的患病率、影响和经济意义:取得了哪些进展?

The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made?

机构信息

Stroke and Ageing Research Centre, Department of Medicine, Monash Medical Centre, Southern Clinical School, Monash University, Melbourne, Vic., Australia.

出版信息

Neuroepidemiology. 2013;40(4):227-39. doi: 10.1159/000343667. Epub 2013 Jan 24.

DOI:10.1159/000343667
PMID:23364221
Abstract

Atrial fibrillation (AF) is a major risk factor for stroke, especially in the elderly. Increased life expectancies mean that AF-related stroke is a growing global public health concern. Improvements in the detection, treatment and prevention of the consequences of AF have occurred in recent years. However, the extent to which these improvements have impacted on the prevalence of AF, the risk of AF-related stroke and subsequent economic costs are unknown. This review provides a contemporary assessment of the epidemiological data on AF-related stroke aimed at assessing the effectiveness of primary prevention strategies and associated economic implications with reductions in stroke incidence. A systematic review of the literature was performed. Appropriately designed studies were identified and retrieved. Evidence on changes in the prevalence of AF, the risk of stroke associated with AF and the excess cost of AF-related stroke over the last 30 years was summarised. The results provide evidence that the age-adjusted prevalence of AF and the relative risk of stroke associated with AF has remained relatively constant. Unless action is taken to improve detection of AF and reduce its consequences, a considerable increase in the social and economic burden associated with AF-related stroke is likely.

摘要

心房颤动(AF)是中风的一个主要危险因素,尤其是在老年人中。预期寿命的延长意味着与 AF 相关的中风是一个日益严重的全球公共卫生问题。近年来,在 AF 的检测、治疗和预防后果方面已经取得了一些进展。然而,这些改进在多大程度上影响了 AF 的患病率、AF 相关中风的风险以及随后的经济成本尚不清楚。本综述提供了 AF 相关中风的流行病学数据的最新评估,旨在评估初级预防策略的有效性及其与中风发病率降低相关的经济影响。进行了系统的文献综述。确定并检索了设计适当的研究。总结了过去 30 年来 AF 的患病率变化、与 AF 相关的中风风险以及 AF 相关中风的超额成本的证据。结果表明,AF 的年龄调整患病率和与 AF 相关的中风风险的相对风险相对稳定。除非采取措施提高 AF 的检出率并降低其后果,否则与 AF 相关的中风相关的社会和经济负担很可能会大幅增加。

相似文献

1
The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made?心房颤动在卒中中的患病率、影响和经济意义:取得了哪些进展?
Neuroepidemiology. 2013;40(4):227-39. doi: 10.1159/000343667. Epub 2013 Jan 24.
2
Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation.新发心房颤动患者的超声心动图:系统评价和经济评估。
Health Technol Assess. 2013 Aug;17(36):1-263, v-vi. doi: 10.3310/hta17360.
3
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
4
Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.“口袋里的药丸”策略与偶发性院内治疗或持续性抗心律失常药物治疗相比,用于阵发性心房颤动的系统评价和成本效益评估。
Health Technol Assess. 2010 Jun;14(31):iii-iv, 1-75. doi: 10.3310/hta14310.
5
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
6
The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.缺血性卒中对房颤相关医疗费用的影响:系统评价。
Europace. 2017 Jun 1;19(6):937-947. doi: 10.1093/europace/euw093.
7
The Global Burden of Atrial Fibrillation and Stroke: A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia.全球心房颤动和中风负担:亚洲心房颤动临床流行病学的系统评价。
Chest. 2017 Oct;152(4):810-820. doi: 10.1016/j.chest.2017.03.048. Epub 2017 Apr 17.
8
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.心房颤动中的中风与血栓栓塞:中风危险因素、风险分层方案及成本效益数据的系统评价
Thromb Haemost. 2008 Feb;99(2):295-304. doi: 10.1160/TH07-08-0508.
9
Systematic screening for the detection of atrial fibrillation.用于检测心房颤动的系统筛查。
Cochrane Database Syst Rev. 2016 Jun 3;2016(6):CD009586. doi: 10.1002/14651858.CD009586.pub3.
10
Effectiveness of systematic screening for the detection of atrial fibrillation.系统性筛查用于检测心房颤动的有效性。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD009586. doi: 10.1002/14651858.CD009586.pub2.

引用本文的文献

1
ECG-based beat-to-beat assessment of AV node conduction properties during AF.基于心电图的房颤期间房室结传导特性的逐搏评估。
Front Physiol. 2025 Aug 1;16:1624403. doi: 10.3389/fphys.2025.1624403. eCollection 2025.
2
Comparative clinical profiles and outcomes of prior vs. concurrently diagnosed atrial fibrillation in acute ischaemic stroke: the implication of diagnosis timing.急性缺血性卒中患者既往诊断与同时诊断心房颤动的临床特征及结局比较:诊断时机的影响
Europace. 2025 Jun 3;27(6). doi: 10.1093/europace/euaf107.
3
Secondary Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation and Advanced Chronic Kidney Disease.
非瓣膜性心房颤动合并晚期慢性肾脏病患者的卒中二级预防
J Atheroscler Thromb. 2025 Jul 1;32(7):873-886. doi: 10.5551/jat.65186. Epub 2025 Jan 24.
4
Hospitalizations of Patients with Atrial Fibrillation (AF) in Poland: A Nationwide Study Based on over One Million AF Hospitalizations in 2017-2021.波兰心房颤动(AF)患者的住院情况:一项基于2017 - 2021年超过100万例AF住院病例的全国性研究。
J Clin Med. 2024 Nov 2;13(21):6592. doi: 10.3390/jcm13216592.
5
Epidemiology and clinical implications of atrial fibrillation among stroke patients in Ethiopia: a comprehensive systematic review and meta-analysis.在埃塞俄比亚,中风患者中心房颤动的流行病学和临床意义:全面的系统评价和荟萃分析。
BMC Neurol. 2024 Oct 14;24(1):391. doi: 10.1186/s12883-024-03894-8.
6
Comparison of oral anticoagulants for stroke prevention in atrial fibrillation using the UK clinical practice research Datalink Aurum: A reference trial (ARISTOTLE) emulation study.使用英国临床实践研究数据链接 Aurum 对心房颤动卒中预防的口服抗凝药物进行比较:参考试验(ARISTOTLE)仿真研究。
PLoS Med. 2024 Aug 29;21(8):e1004377. doi: 10.1371/journal.pmed.1004377. eCollection 2024 Aug.
7
Predictors of Low Voltage Zone and Sex Differences in Low Voltage Zone Distribution in Patients with Atrial Fibrillation.心房颤动患者低电压区的预测因素及低电压区分布的性别差异
Rev Cardiovasc Med. 2023 Nov 23;24(11):324. doi: 10.31083/j.rcm2411324. eCollection 2023 Nov.
8
Model-based estimation of AV-nodal refractory period and conduction delay trends from ECG.基于模型从心电图估计房室结不应期和传导延迟趋势。
Front Physiol. 2024 Jan 12;14:1287365. doi: 10.3389/fphys.2023.1287365. eCollection 2023.
9
Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?心房颤动患者经皮冠状动脉介入治疗12个月后停用抗血小板治疗真的安全吗?
Interv Cardiol. 2023 Jun 13;18:e22. doi: 10.15420/icr.2022.40. eCollection 2023.
10
Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation.骨形态发生蛋白 10-预测心房颤动患者不良结局的新型生物标志物。
J Am Heart Assoc. 2023 Mar 21;12(6):e028255. doi: 10.1161/JAHA.122.028255. Epub 2023 Mar 16.